- Home
- / Malin Corporation
Malin Corporation
Stock Price
€5.8
2024-10-29
Market Capitalization
€112.4 M
2024-10-29
Malin Corporation Summary
Company Summary
- Overview
- Malin Corporation is a company that invests in life sciences and healthcare technologies. Its therapeutic areas of focus include oncology, immunology, and genetic diseases. The company provides long-term capital and strategic support to its investee companies.
- Type
- Public
- Status
- Active
- Founded
- 2015
- HQ
- Dublin, IE | view all locations
- Website
- http://www.malinplc.com/
- Cybersecurity rating
Table of Contents
Key People
Liam Daniel, Chair
Rudy Mareel, Lead Independent Non-Executive Director
Chris Pedrick, Non-Executive Director
Operating MetricsView all
Estimated Intrinsic Equity Value per Ordinary Share
€6.3
17.9%
H1, 2023
Estimated Fair Value of Investee Companies
€118.7M
54.1%
H1, 2023
LocationsView all
1 location detected
Dublin, County Dublin HQ
Ireland
The Lennox Building, 50 Richmond Street South
Malin Corporation Financials
Summary Financials
- Net income (FY, 2025)
- (€6.9M)
- Cash (FY, 2025)
- €12.9M
- EBIT (FY, 2025)
- (€2.7M)